Corbin A, Richardson J, Denesvre C, Pozo F, Ellerbrok H, Sitbon M
Laboratoire d'Oncologie Cellulaire et Moléculaire, Unité INSERM 363, Institu Cochin de Génétique Moléculaire (ICGM), Université Paris V, France.
Virology. 1994 Jul;202(1):70-5. doi: 10.1006/viro.1994.1323.
In cell cultures infected with a retrovirus, the expression of the viral envelope interferes with superinfection by retroviruses which recognize the same receptor. We have previously demonstrated that vaccination of susceptible strains of mice (of the Mus musculus species) with the attenuated ecotropic Friend murine leukemia virus (F-MuLV) B3 efficiently protects against the early hemolytic anemia and the erythroleukemia induced by a challenge with the virulent F-MuLV 57 through a similar in vivo mechanism of interference to superinfection (A. Corbin and M. Sitbon, J. Virol. 67, 5146-5152, 1993). Vaccination with the heterologous ecotropic Moloney-MuLV (M-MuLV) efficiently protects against the early hemolytic anemia but has a weak protective effect on the F-MuLV 57-induced erythroleukemia. Furthermore, vaccination with the attenuated F-MuLV B3 had only a transient protective effect on M-MuLV-induced thymomas. These different efficiencies of F- and M-MuLV to confer protection in this model of vaccination by interference were mostly due to envelope sequences, indicative of distinct in vivo interference properties of the two ecotropic envelopes.
在感染逆转录病毒的细胞培养物中,病毒包膜的表达会干扰识别相同受体的逆转录病毒的重复感染。我们之前已经证明,用减毒的亲嗜性弗氏小鼠白血病病毒(F-MuLV)B3对易感品系的小鼠(小家鼠种)进行疫苗接种,可通过类似的体内重复感染干扰机制,有效预防由强毒力的F-MuLV 57攻击所诱导的早期溶血性贫血和红白血病(A. 科尔宾和M. 西邦,《病毒学杂志》67卷,5146 - 5152页,1993年)。用异源亲嗜性莫洛尼氏MuLV(M-MuLV)进行疫苗接种可有效预防早期溶血性贫血,但对F-MuLV 57诱导的红白血病的保护作用较弱。此外,用减毒的F-MuLV B3进行疫苗接种对M-MuLV诱导的胸腺瘤只有短暂的保护作用。在这种通过干扰进行疫苗接种的模型中,F-MuLV和M-MuLV赋予保护的不同效率主要归因于包膜序列,这表明两种亲嗜性包膜在体内具有不同的干扰特性。